Back to Agenda
Session 7: Relative Efficacy versus Relative Effectiveness – the Future
Session Chair(s)
François Meyer, MD
Advisor to the President, International Affairs
French National Authority for Health (HAS), France
- Current challenges in the assessment of relative efficacy/effectiveness
- The need for comparative data
- Role of EUnetHTA moving forward
- Cooperation between EMA and EUnetHTA: current status and perspectives
Speaker(s)
Leeza Osipenko, PhD, MSc
Head of Scientific Advice
National Institute for Health and Care Excellence (NICE), United Kingdom
Kristin Svanqvist, MPharm
Governmental Affairs Manager
Amgen, Norway
Michael Berntgen, PhD
Head of Scientific Evidence Generation
European Medicines Agency, Netherlands
Have an account?